Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 217-044-3 | CAS number: 1729-67-5
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
Skin sensitisation:
A DEREK assessment, DPRA assay and a KeratinoSensTM assay were available.
A DEREK prediction on the skin sensitizing potential of test item was positive based on the presence of an alkyl halide. The DPRA was positive as test item depleted all SPCC and SPCL. The substance was classified in the "high reactivity class". The KeratinoSensTM assay outcome was positive as a biologically relevant activation of the antioxidant/electrophile responsive element (ARE)-dependent pathway was observed at low concentrations at non-cytotoxic concentrations. Based on the results, it is concluded that test item is a skin sensitizer. The EC3 of 4.4% was predicted based on structural analogues of test item was not sufficiently reliable to differentiate between skin sensitization category 1A and 1B. As no reliable potency prediction can be made on the available data and as the substance is classified as corrosive (category 1) no in vivo testing to determine potency on skin sensitization needs to be conducted.
Key value for chemical safety assessment
Skin sensitisation
Link to relevant study records
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- (Q)SAR
- Adequacy of study:
- weight of evidence
- Study period:
- 2018-11-20
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- results derived from a valid (Q)SAR model and falling into its applicability domain, with adequate and reliable documentation / justification
- Justification for type of information:
- See attached justification
- Qualifier:
- no guideline followed
- Principles of method if other than guideline:
- - Software tool(s) used including version:
DEREK NEXUS version 6.0.1
- Model(s) used: DEREK NEXUS
- Model description: see field 'Attached justification'
- Justification of QSAR prediction: see field 'Attached justification' - GLP compliance:
- no
- Key result
- Parameter:
- other: EC3 / %
- Value:
- 4.4
- Remarks on result:
- other: moderate sensitizer
- Other effects / acceptance of results:
- DEREK NEXUS version 6.0.1 yielded an alert for skin sensitization for the test item. The test item is predicted to be sensitizing to the skin (plausible). DEREK NEXUS predicted an EC3 for the test item of 4.4% (moderate sensitizer), based on local lymph node assay (LLNA) and the guinea pig maximisation test (GPMT) data of 15 closest structurally related substances that had a structural similarity between 15 and 44%.
- Interpretation of results:
- other: Sensitizing
- Conclusions:
- The test item is predicted to be sensitizing to the skin (plausible).
- Executive summary:
The potential for skin sensitization of test item was predicted with the in silico model DEREK NEXUS. In this assessment version 6.0.1 of DEREK NEXUS was used.
DEREK NEXUS version 6.0.1 yielded an alert for skin sensitization for the test item. The test item is predicted to be sensitizing to the skin (plausible). DEREK NEXUS predicted an EC3 for the test item of 4.4% (moderate sensitizer), based on local lymph node assay (LLNA) and the guinea pig maximisation test (GPMT) data of 15 closest structurally related substances that had a structural similarity between 15 and 44%.
- Endpoint:
- skin sensitisation: in chemico
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From 2019-02-05 to 2019-02-12
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed to current OECD guidelines with no significant deviations and run in OECD GLP certified lab.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA))
- Version / remarks:
- 2015
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- other: Direct Peptide Reactivity Assay (DPRA)
- Specific details on test material used for the study:
- Purity: 98%
Batch No.: 800327680 - Details on the study design:
- TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 46.54 mg for both the cysteine and lysine reactivity assay
- Purity: 98%
SOLVENT USED: Acetonitrile (ACN)
POSITIVE CONTROL USED
- Solutions for Cysteine Reactivity Assay: 750 µL Stock solution of 0.667 mM SPCC (Synthetic Peptide Containing Cysteine) + 200 µL ACN + 50 µL Cinnamic aldehyde solution (100 mM in ACN)
- Solutions for Lysine Reactivity Assay: 750 µL Stock solution of 0.667 mM SPCL (Synthetic Peptide Containing Lysine) + 250 µL Cinnamic aldehyde solution (100 mM in ACN)
CO-ELUTION CONTROL (CC):
- Solutions for Cysteine Reactivity Assay: 750 µL Phosphate buffer pH 7.5 + 200 µL ACN + 50 µL test solution (100 mM)
- Solutions for Lysine Reactivity Assay: 750 µL Ammonium acetate buffer pH 10.2 + 250 µL test solution (100 mM)
REFERENCE CONTROL
- Solutions for Cysteine Reactivity Assay: 750 µL of the 0.667 mM SPCC stock solution + 250 µL ACN.
- Solutions for Lysine Reactivity Assay: 750 µL of the 0.667 mM SPCL stock solution + 250 µL ACN.
NUMBER OF REPLICATES
Co-elution control (CC) samples: 1 for both the cysteine and lysine reactivity assay
Positive control samples: 3 each for both the cysteine and lysine reactivity assay
Test item: 3 each for both the cysteine and lysine reactivity assay
Reference Control samples: 3 each for both the cysteine and lysine reactivity assay
SAMPLE INCUBATIONS
The samples (reference controls, calibration solutions, co-elution control, positive controls and test item samples) were placed in the autosampler in the dark and incubated at 25 ± 2.5 °C.
The incubation time between placement of the samples in the autosampler and analysis of the first RCcysB- or RClysB-sample was 23 hours. The time between the first RCcysB- or RClysB-injection and the last injection of a cysteine or lysine sequence, respectively, did not exceed 30 hours. - Positive control results:
- Cysteine Reactivity Assay
The mean Percent SPCC Depletion for the positive control cinnamic aldehyde was 72.1% ± 0.1%. This was within the acceptance range of 60.8% to 100% with a SD that was below the maximum (SD <14.9%).
Lysine Reactivity Assay
The mean Percent SPCL Depletion for the positive control cinnamic aldehyde was 64.8% ± 1.7%. This was within the acceptance range of 40.2% to 69.0% with a SD that was below the maximum (SD <11.6%). - Key result
- Run / experiment:
- other: Cysteine Reactivity Assay
- Parameter:
- other: SPCC depletion%
- Value:
- 100
- Positive controls validity:
- valid
- Remarks on result:
- other: the mean SPCC depletion of the test item
- Key result
- Run / experiment:
- other: Lysine Reactivity Assay
- Parameter:
- other: SPCL depletion%
- Value:
- 93.8
- Positive controls validity:
- valid
- Remarks on result:
- other: the mean SPCL depletion of the test item
- Other effects / acceptance of results:
- - Precipitation: No precipitate or phase separation was observed in any of the samples while after incubation, a phase separation was only observed in the SPCC test item samples.
- Test Acceptability: all acceptability criteria were met this DPRA is considered to be valid. - Interpretation of results:
- other: positive
- Conclusions:
- The test item was considered to be positive in the DPRA and classified in the "high reactivity class" when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Executive summary:
The objective of this study was to determine the reactivity of the test substance towards model synthetic peptides containing either cysteine (SPCC) or lysine (SPCL) according to OCED Guideline 442C (In Chemico Skin Sensitisation: Direct Peptide Reactivity Assay (DPRA)).
After incubation of the test item with either SPCC or SPCL, the relative peptide concentration was determined by High-Performance Liquid Chromatography (HPLC) with gradient elution and spectrophotometric detection at 220 nm and 258 nm. SPCC and SPCL Percent Depletion Values were calculated and used in a prediction model which allows assigning the test item to one of four reactivity classes used to support the discrimination between sensitizers and non-sensitizers.
Upon preparation of the SPCC and SPCL test item samples, no precipitate or phase separation was observed in any of the samples while after incubation, a phase separation was only observed in the SPCC test item samples.
In the cysteine reactivity assay the test item showed 100.0% SPCC depletion while in the lysine reactivity assay the test item showed 93.8% SPCL depletion. The mean of the SPCC and SPCL depletion was 96.9%.
As a result the test item was considered to be positive in the DPRA and classified in the "high reactivity class" when using the Cysteine 1:10 / Lysine 1:50 prediction model.
- Endpoint:
- skin sensitisation: in vitro
- Type of information:
- experimental study
- Adequacy of study:
- weight of evidence
- Study period:
- From 2019-01-16 to 2019-04-05
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Remarks:
- Study performed to current OECD guidelines with no significant deviations and run in OECD GLP certified lab.
- Qualifier:
- according to guideline
- Guideline:
- OECD Guideline 442D (In Vitro Skin Sensitisation: ARE-Nrf2 Luciferase Test Method)
- Version / remarks:
- 2018
- Deviations:
- no
- GLP compliance:
- yes
- Type of study:
- activation of keratinocytes
- Justification for non-LLNA method:
- The existing knowledge of the chemical and biological mechanisms associated with skin sensitization has been summarized in the form of an Adverse Outcome Pathway (AOP). The second key event in this AOP takes place in the keratinocytes and includes inflammatory responses as well as gene expression associated with specific cell signaling (stress) pathways such as the antioxidant/ electrophile response element (ARE)-dependent pathways.
The KeratinoSensTM test (an ARE-Nrf2 luciferase reporter assay) is proposed to address this second key event. Skin sensitizers have been reported to induce genes that are regulated by the antioxidant response element (ARE). Small electrophilic substances such as skin sensitisers can act on the sensor protein Keap1 (Kelch-like ECH-associated protein 1), by e.g. covalent modification of its cysteine residue, resulting in its dissociation from the transcription factor Nrf2 (nuclear factor-erythroid 2-related factor 2). The dissociated Nrf2 can then activate ARE-dependent genes such as those coding for phase II detoxifying enzymes. In the KeratinoSensTM cell line activation of the Nrf2 pathway results in luciferase expression which can be quantified easily. - Specific details on test material used for the study:
- Purity: 98%
Batch No.: 800327680 - Details on the study design:
- Plating of Cells
For testing, cells were 80-90% confluent. One day prior to testing cells were harvested, and distributed into 96-well plates (10,000 cells/well) in basic medium. For each repetition, three replicates were used for the luciferase activity measurements, and one parallel replicate used for the MTT cell viability assay. The cells were incubated overnight in the incubator. The passage number used was P+13 in experiment 1 and P+6 in experiment 2.
Treatment of Cells
The medium was removed and replaced with fresh culture medium (150 μL culture medium containing serum but without Geneticin) to which 50 μL of the 25-fold diluted test chemical and control items were added. Three wells per plate were left empty (no cells and no treatment) to assess background values. The treated plates were covered with foil and then incubated for about 48 hours ± 1 h at 37±1.0 °C in the presence of 5% CO2. Initially, experiment 1and 2 did not pass all the acceptability criteria and therefore this experiment was repeated. In total 2 valid experiments were performed.
Luciferase Activity Measurement
The Steady-Glo Luciferase Assay Buffer (10 mL) and Steady-Glo Luciferase Assay Substrate (lyophilized) from Promega (Leiden, The Netherlands) were mixed together. The assay plates were removed from the incubator and the medium is removed. Then 200 µL of the Steady-Glo Luciferase substrate solution (prior to addition 1:1 mixed with exposure medium) was added to each well. The plates were shaken for at least 5 minutes at room temperature. Plates with the cell lysates were placed in the TECAN Infinite® M200 Pro Plate Reader to assess the quantity of luciferase (integration time two seconds).
Cytotoxicity Assessment
For the KeratinoSensTM cell viability assay, medium was replaced after the 48 hour exposure time with fresh medium containing MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5diphenyltetrazolium bromide, Thiazolyl blue tetrazolium bromide; CAS No. 298-93-1; Sigma, Zwijndrecht, The Netherlands) and cells were incubated for 3 - 4 hours at 37 °C ± 1.0 °C in the presence of 5% CO2. The MTT medium was then removed and cells were lysed overnight by adding 10% SDS solution (Sigma, Zwijndrecht, The Netherlands) to each well. After shaking, the absorption was measured at 570 nm with the TECAN Infinite® M200 Pro Plate Reader. - Positive control results:
- Experiment 1:
The positive control Ethylene dimethacrylate glycol caused a dose related induction of the luciferase activity. The Imax was 3.71 and the EC(1.5) 20 µM.
Experiment 2:
The positive control Ethylene dimethacrylate glycol caused a dose related induction of the luciferase activity. The Imax was 2.12 and the EC(1.5) 56 µM. - Key result
- Run / experiment:
- other: 1
- Parameter:
- other: Imax
- Remarks:
- The maximal average fold induction of luciferase activity
- Value:
- 3.27
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Key result
- Run / experiment:
- other: 2
- Parameter:
- other: Imax
- Remarks:
- The maximal average fold induction of luciferase activity value
- Value:
- 4.86
- Vehicle controls validity:
- valid
- Positive controls validity:
- valid
- Remarks on result:
- positive indication of skin sensitisation
- Other effects / acceptance of results:
- ACCEPTANCE OF RESULTS:
The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
The EC1.5 of the positive control was within two standard deviations of the historical mean (20 μM and 56 μM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 μM was higher than 2-fold (3.71-fold and 2.12-fold in experiment 1 and 2, respectively).
Finally, the average coefficient of variation of the luminescence reading for the vehicle (negative) control DMSO was below 20% (11% and 8.1% in experiment 1 and 2, respectively).
Overall it is concluded that the test conditions were adequate and that the test system functioned properly. - Interpretation of results:
- other: positive
- Conclusions:
- The test item showed toxicity (IC30 values of 30 μM and 12 μM and IC50 values of 39 μM and 14 μM in experiment 1 and 2, respectively). A biologically relevant, dose-related induction of the luciferase activity (EC1.5 values of 9.6 μM and 5.7 μM in experiment 1 and 2, respectively) was measured in both experiments. The maximum luciferase activity induction (Imax) was 3.27-fold and 4.86-fold in experiment 1 and 2 respectively. The test item is classified as positive in the KeratinoSensTM assay since positive results (>1.5-fold induction) were observed at test concentrations < 1000 μM with a cell viability of >70% compared to the vehicle control.
- Executive summary:
The objective of this study was to evaluate the ability of the test item to activate the antioxidant/electrophile responsive element (ARE)-dependent pathway in the KeratinoSens assay based on the most recent OECD Guideline 442D.
The test item was dissolved in dimethyl sulfoxide at 200 mM. From this stock 11 spike solutions in DMSO were prepared. The stock and spike solutions were diluted 100-fold in the assay resulting in test concentrations of 0.98 - 2000 µM (2-fold dilution series). The highest test concentration was the highest dose required in the current guideline. In the second experiment, a more narrow dose-response analysis was performed using a lower dilution factor of 1.5-fold to investigate the induction in experiment 1 in more detail. No precipitate was observed at any dose level tested. Two independent experiments were performed.
Both experiments passed the acceptance criteria:
The luciferase activity induction obtained with the positive control, Ethylene dimethacrylate glycol, was statistically significant above the threshold of 1.5-fold in at least one concentration.
The EC1.5 of the positive control was within two standard deviations of the historical mean (20 μM and 56 μM in experiment 1 and 2, respectively). A dose response was observed and the induction at 250 μM was higher than 2-fold (3.71-fold and 2.12-fold in experiment 1 and 2, respectively).
Finally, the average coefficient of variation of the luminescence reading for the vehicle (negative) control DMSO was below 20% (11% and 8.1% in experiment 1 and 2, respectively).
Overall it is concluded that the test conditions were adequate and that the test system functioned properly.
The test item showed toxicity (IC30 values of 30 μM and 12 μM and IC50 values of 39 μM and 14 μM in experiment 1 and 2, respectively). A biologically relevant, dose-related induction of the luciferase activity (EC1.5 values of 9.6 μM and 5.7 μM in experiment 1 and 2, respectively) was measured in both experiments. The maximum luciferase activity induction (Imax) was 3.27-fold and 4.86-fold in experiment 1 and 2 respectively. The test item is classified as positive in the KeratinoSensTM assay since positive results (>1.5-fold induction) were observed at test concentrations < 1000 μM with a cell viability of >70% compared to the vehicle control.
In conclusion, the test item is classified as positive (activation of the antioxidant/electrophile responsive element (ARE)-dependent pathway in keratinocytes) under the experimental conditions described in this report.
Referenceopen allclose all
In the cysteine reactivity assay the test item showed 100.0% SPCC depletion while in the lysine reactivity assay the test item showed 93.8% SPCL depletion. The mean of the SPCC and SPCL depletion was 96.9% and as a result the test item was considered to be positive in the DPRA and classified in the “highreactivityclass” when using the Cysteine 1:10 / Lysine 1:50 prediction model.
Experiment 1
No precipitation was observed at the start and end of the incubation period in the 96-well plates.
The test item showed toxicity. The calculated IC30 was 30 μM and the calculated IC50 was 39 μM.
A dose related luminescence activity induction was observed after treatment with the test item. The Imax was 3.27 and the EC1.5 9.6 μM.
The positive control Ethylene dimethacrylate glycol caused a dose related induction of the luciferase activity. The Imax was 3.71 and the EC1.5 20 μM.
Experiment 2
No precipitation was observed at the start and end of the incubation period in the 96-well plates.
The test item showed toxicity. The calculated IC30 was 12 μM and the calculated IC50 was 14 μM.
A dose related luminescence activity induction was observed after treatment with the test item. The Imax was 4.86 and the EC1.5 5.7 μM.
The positive control Ethylene dimethacrylate glycol caused a dose related induction of the luciferase activity. The Imax was 2.12 and the EC1.5 56 μM.
Endpoint conclusion
- Endpoint conclusion:
- adverse effect observed (sensitising)
Respiratory sensitisation
Endpoint conclusion
- Endpoint conclusion:
- no study available
Justification for classification or non-classification
Skin sensitisation:
Positive results in DEREK assessment, DPRA assay and KeratinoSensTM assay.
According to Regulation (EC) No 1272/2008, table 3.4.2, this substance should be classified as category 1 for this endpoint.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.